Ventromedial hypothalamic lesions enhance small intestinal cell proliferation in mice

Inoue, 1977, Effect of transplantation of pancreas on development of hypothalamic obesity, Nature, 266, 742, 10.1038/266742a0 Inoue, 1979, An autonomic hypothesis for hypothalamic obesity, Life Sci, 25, 561, 10.1016/0024-3205(79)90549-6 Bray, 1979, Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis, Physiol Rev, 59, 719, 10.1152/physrev.1979.59.3.719 Satoh, 1997, Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats, Endocrinology, 138, 947, 10.1210/endo.138.3.4989 Suga, 1999, Rapid increase in circulating leptin in ventromedial hypothalamus-lesioned rats: role of hyperinsulinemia and implication for upregulating mechanism, Diabetes, 48, 2034, 10.2337/diabetes.48.10.2034 Yoshimatsu, 1984, Effects of hypothalamic lesion on pancreatic autonomic nerve activity in the rat, Brain Res, 303, 147, 10.1016/0006-8993(84)90222-1 Inoue, 1977, The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity, Endocrinology, 100, 108, 10.1210/endo-100-1-108 Kiba, 1991, Comparison of DNA contents of visceral organs in rats with ventromedial hypothalamic lesions and fed a high fat diet, Neurosci Lett, 126, 127, 10.1016/0304-3940(91)90535-2 Kiba, 1993, Ventromedial hypothalamic lesions increase gastrointestinal DNA synthesis through vagus nerve in rats, Gastroenterology, 104, 475, 10.1016/0016-5085(93)90416-A Kiba, 1992, Role of vagus nerve in increased DNA synthesis after hypothalamic ventromedial lesions in rat liver, Am J Physiol, 262, G483 Kiba, 1996, Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation, Gastroenterology, 110, 885, 10.1053/gast.1996.v110.pm8608899 Pereira, 2006, New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome, J Gastroenterol Hepatol, 21, 932, 10.1111/j.1440-1746.2006.04351.x Suzuki, 2011, Cell proliferation in visceral organs induced by ventromedial hypothalamic (VMH) lesions: development of electrical VMH lesions in mice and resulting pathophysiological profiles, Endocr J, 58, 247, 10.1507/endocrj.K10E-408 Hall, 1990, Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms, J Pathol, 162, 285, 10.1002/path.1711620403 Saftoiu, 2003, Immunohistochemical assessment of proliferating cell nuclear antigen in primary hepatocellular carcinoma and dysplastic nodules, J Cell Mol Med, 7, 436, 10.1111/j.1582-4934.2003.tb00246.x Simons, 2011, Stem cell self-renewal in intestinal crypt, Exp Cell Res, 317, 2719, 10.1016/j.yexcr.2011.07.010 Haapasalo, 1989, Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms, Pathol Res Pract, 185, 551, 10.1016/S0344-0338(89)80191-8 Kintaka, 2009, Effects of gastric vagotomy on visceral cell proliferation induced by ventromedial hypothalamic lesions: role of vagal hyperactivity, J Mol Neurosci, 38, 243, 10.1007/s12031-009-9200-0 Riccio, 2008, Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2, EMBO Rep, 9, 377, 10.1038/embor.2008.7 Nightingale, 2006, Guidelines for management of patients with a short bowel, Gut, 55, iv1, 10.1136/gut.2006.091108 Ekema, 2009, Total parenteral nutrition in patients with short bowel syndrome, Minerva Pediatr, 61, 283 DeLegge, 2007, Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today?, Dig Dis Sci, 52, 876, 10.1007/s10620-006-9416-6 McMellen, 2010, Growth factors: possible roles for clinical management of the short bowel syndrome, Semin Pediatr Surg, 19, 35, 10.1053/j.sempedsurg.2009.11.010 Wales, 2010, Human growth hormone and glutamine for patients with short bowel syndrome, Cochrane Database Syst Rev, 16, CD006321 Wallis, 2009, Short bowel syndrome: the role of GLP-2 on improving outcome, Curr Opin Clin Nutr Metab Care, 5, 526, 10.1097/MCO.0b013e32832d23cd